FORE-SIGHT provides clinically relevant, absolute measurements that clearly indicate a patient’s cerebral tissue oxygen saturation status. This vital information enables clinicians to identify and react to instances of lowered brain oxygen saturation before the situation becomes critical.
The brain has the highest metabolic rate of any organ in the body. With oxygen reserves of only about 8-10 seconds at normal body temperatures, it is one of the organs most vulnerable to oxygen deprivation.
Brain protection from low oxygen levels during surgical procedures or in the ICU is an important goal of any clinical team. Cerebral tissue oxygen saturation (SctO2) is especially essential to high risk cardiovascular surgical teams who are often required to interrupt, re-route or stop normal brain circulation.
Until FORE-SIGHT, an FDA cleared device allowing clinicians to non-invasively and accurately Monitor absolute SctO2 had not been available.
Solution:
The CAS Medical Systems (CASMED®) FORE-SIGHT Cerebral Oximeter non-invasively and continuously measures absolute brain tissue oxygen saturation, enabling clinicians to identify and react to instances of lowered brain oxygen saturation before the situation becomes critical.
With sensors placed on the patient’s forehead, FORE-SIGHT utilizes CASMED’s advanced LASER-SIGHT®Optical Technology to project near infrared light into an area of the brain that is most susceptible to low oxygen levels. LASER-SIGHT then measures and quantifies specific elements found in the blood and brain tissue. FORE-SIGHT’s patented algorithms translate this information to an absolute SctO2 measurement. SctO2 is displayed on the FORE-SIGHT monitor screen and updated every two seconds.
